The following is an excerpt.
CHICAGO, April 23 (Reuters) – AquaBounty Technologies Inc expects regulatory approval by the fourth quarter of this year to produce its controversial genetically engineered salmon, its chief executive said on Tuesday.
“There have been no new legal issues, no new regulatory issues, no new environmental issues raised,” AquaBounty Technologies Chief Executive Ronald Stotish said on the sidelines of the BIO International Convention. “We should have approval before the end of the year.”
The U.S. Food and Drug Administration is due to close a public comment period on Friday and will then likely take 30 to 60 days to review the comments, which include heavy opposition from consumer and environmental groups.
It could take another 120 days after that for the FDA to issue final approval, Stotish said.
View the original article here: Genetically engineered salmon company expects US regulatory OK in 2013